Organization
Medicome Sp. z o.o., Oswiecim, Poland
1 abstract
Abstract
A PHASE III RANDOMISED, DOUBLE-BLIND CLINICAL STUDY COMPARING SB4, AN ETANERCEPT BIOSIMILAR, WITH ETANERCEPT REFERENCE PRODUCT (ENBREL®) IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY (24-WEEK RESULTS) Org: NZOZ Medica Pro Familia Sp. z o.o., Warsaw, Poznanski Osrodek Medyczny NOVAMED, Poznan, Poland, Medicome Sp. z o.o., Oswiecim, Poland, Samsung Bioepis Co., Ltd., Incheon, Korea, Republic Of,